首页> 美国卫生研究院文献>International Journal of Environmental Research and Public Health >Escherichia coli Antimicrobial Susceptibility Reduction amongst HIV-Infected Individuals at the University Teaching Hospital Lusaka Zambia
【2h】

Escherichia coli Antimicrobial Susceptibility Reduction amongst HIV-Infected Individuals at the University Teaching Hospital Lusaka Zambia

机译:赞比亚卢萨卡大学教学医院的艾滋病毒感染者中降低大肠杆菌的药敏性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Increased antimicrobial resistance among Human Immunodeficiency Virus (HIV)-infected individuals to commonly used antibiotics in the treatment of gastroenteritis is a public health concern, especially in resource-limited settings. We set out to compare the antimicrobial susceptibility pattern of isolates from HIV-infected and HIV-uninfected individuals at a tertiary hospital in Lusaka, Zambia. An analytical cross-sectional study was conducted at the University Teaching Hospital from May 2019 to August 2019. Stool samples were screened, and 79 HIV-infected individuals matched by age and sex with 84 HIV-uninfected individuals that presented with associated gastroenteritis were studied. Demographics were collected from the Laboratory Information System (LIS) and stool samples were collected in a sterile leak-proof container. Samples were cultured and only those where was isolated were included in the study and tested for antimicrobial susceptibility by the Kirby–Bauer disk diffusion technique. HIV-positive individuals were 3 times (adjusted odds ratio (AOR) = 3.17; 95% CI (1.51, 6.66); < 0.001) more likely to be resistant to quinolones compared with their HIV-negative counterparts. Similarly, HIV-positive individuals were almost 4 times (AOR = 3.97, 95% CI (1.37, 11.46); = 0.011) more likely to have multidrug-resistant compared with those who were HIV-negative. HIV infection was associated with reduced susceptibility to commonly used antibiotics, and most cases showed resistance.
机译:感染人类免疫缺陷病毒(HIV)的个体对常用抗生素治疗肠胃炎的抗药性增强是公共健康问题,尤其是在资源有限的环境中。我们着手在赞比亚卢萨卡的一家三级医院比较来自HIV感染者和HIV未感染者的分离株的抗菌药敏模式。从2019年5月至2019年8月在大学教学医院进行了分析性横断面研究。对粪便样本进行了筛选,研究了79名按年龄和性别匹配的HIV感染者和84例伴有肠胃炎的HIV未感染者。从实验室信息系统(LIS)收集人口统计资料,并在无菌防漏容器中收集粪便样本。培养样品,仅将分离出的样品包括在研究中,并通过Kirby-Bauer纸片扩散技术测试其药敏性。与HIV阴性的人相比,HIV阳性的人对喹诺酮类药物耐药的可能性高3倍(调整比值比(AOR)= 3.17; 95%CI(1.51,6.66); <0.001)。同样,与HIV阴性的人相比,HIV阳性的人具有多重耐药性的可能性要高出近4倍(AOR = 3.97,95%CI(1.37,11.46); = 0.011)。 HIV感染与对常用抗生素的敏感性降低有关,大多数病例显示出耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号